By: Michael Robinson
I love learning about cannabis.
Over the last three decades I’ve parsed all kinds of cannabis information of varying quality. Though misinformation (e.g., broad leaf varieties are higher in CBD than narrow leaf ones) and disinformation (e.g., cannabis is a gateway drug) persist, there are true facts out there – and more and more data is becoming available as legalization un-yokes us from the previously unyielding barriers that have prevented so much meaningful investigation.
There is much to learn about this plant. From our at least 6000-year history of interacting with it, to the roughly 45,000 unique cannabis products for sale on the shelves of Washington State rec shops, we humans are just beginning to scratch the surface of this trove of enlightening emerald providence.
New tools are emerging to help us make sense of the wide variety of products suddenly available. Sites like Leafly aggregate users’ strain reviews and provide a useful interface for consumers to learn more about others’ experiences. The Phylos Bioscience Strain Galaxy helps us understand the genetic relationships between our favorite varieties and offers useful clues to cannabis…